However, in the tumor microenvironment, elevated IL-17 promotes recruitment of tumor-associated macrophages (TAMs) that suppress the antitumor immune response, enhance cancer cell proliferation, angiogenesis, and tumor progression. The gene discussed is IL17A; the disease is neoplasm.